With branded agents entering generic categories and generics entering the specialty space, many are waiting for payers decisions on utilization management and access restriction. The Spring 2014 edition of the Managed Care Biologics and Injectables Index surveyed 103 payers and a select number of physicians about their expectations for these categories moving in opposite directions. Learn more here. (Source: Ritupriya Yamujala, Zitter Health Insights, 8/12/14).
You are here: / / Are Lines Between Generic And Specialty Getting Blurry?